Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""recurrence"" wg kryterium: Temat


Tytuł :
A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy.
Autorzy :
Liu W; Division of Radiation Oncology, Department of Oncology, London Health Sciences Centre and Western University, London, Canada.
Zukotynski K; Department of Radiology, Hamilton Health Sciences Centre and McMaster University, Hamilton, Canada.
Emmett L; Department of Nuclear Medicine and Theranostics, St. Vincent's Hospital and University of New South Wales, Sydney, Australia.
Chung HT; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Canada.
Chung P; Department of Radiation Oncology, University of Toronto, Toronto, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada.
Wolfson R; Department of Medical Imaging, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, Canada.
Rachinsky I; Division of Nuclear Medicine, London Health Sciences Centre and Western University, London, Canada.
Kapoor A; Urologic Cancer Centre for Research & Innovation and McMaster University, Hamilton, Ontario.
Metser U; Department of Medical Imaging, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada.
Loblaw A; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Canada; University of Toronto, Institute of Health Care Policy and Evaluation, Toronto, Canada.
Morton G; Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Canada.
Sexton T; Division of Radiation Oncology, Department of Oncology, London Health Sciences Centre and Western University, London, Canada.
Lock M; Division of Radiation Oncology, Department of Oncology, London Health Sciences Centre and Western University, London, Canada.
Helou J; Department of Radiation Oncology, University of Toronto, Toronto, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada.
Berlin A; Department of Radiation Oncology, University of Toronto, Toronto, Canada; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada.
Boylan C; Department of Diagnostic Imaging, St. Joseph's Healthcare and McMaster University, Hamilton, Canada.
Archer S; Division of Radiation Oncology, Department of Oncology, London Health Sciences Centre and Western University, London, Canada.
Pond GR; Department of Oncology, McMaster University, Hamilton, Canada.
Bauman G; Division of Radiation Oncology, Department of Oncology, London Health Sciences Centre and Western University, London, Canada. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Mar 01; Vol. 106 (3), pp. 546-555. Date of Electronic Publication: 2019 Nov 12.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Lysine/*analogs & derivatives
Neoplasm Recurrence, Local/*diagnostic imaging
Positron Emission Tomography Computed Tomography/*methods
Prostatic Neoplasms/*diagnostic imaging
Urea/*analogs & derivatives
Aged ; Aged, 80 and over ; Antigens, Surface/blood ; Fluorine Radioisotopes ; Glutamate Carboxypeptidase II/blood ; Humans ; Kallikreins/blood ; Male ; Middle Aged ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/radiotherapy ; Prospective Studies ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/radiotherapy
Czasopismo naukowe
Tytuł :
MRI- and PET-Guided Interstitial Brachytherapy for Postsurgical Vaginal Recurrences of Cervical Cancer: Results of Phase II Study.
Autorzy :
Chopra S; Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, India. Electronic address: .
Engineer R; Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Parel, Mumbai, India.
Shah S; Department of Bioimaging and Nuclear Medicine, Tata Memorial Hospital, Tata Memorial Centre, Parel, Mumbai, India.
Shukla R; Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, India.
Dora T; Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, India.
Gupta P; Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Parel, Mumbai, India.
Paul SN; Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, India.
Popat P; Department of Radiodiagnosis, Tata Memorial Hospital, Tata Memorial Centre, Parel, Mumbai, India.
Swamidas J; Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, India.
Mahantshetty U; Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Parel, Mumbai, India.
Varghese L; Clinical Research Secretariat, Tata Memorial Hospital, Tata Memorial Centre, Parel, Mumbai, India.
Gupta S; Department of Medical Oncology, Tata Memorial Hospital, Tata Memorial Centre, Parel, Mumbai, India.
Rangrajan V; Department of Bioimaging and Nuclear Medicine, Tata Memorial Hospital, Tata Memorial Centre, Parel, Mumbai, India.
Shrivastava S; Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Parel, Mumbai, India.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Feb 01; Vol. 106 (2), pp. 310-319. Date of Electronic Publication: 2019 Nov 01.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Brachytherapy/*methods
Neoplasm Recurrence, Local/*radiotherapy
Radiotherapy, Image-Guided/*methods
Uterine Cervical Neoplasms/*radiotherapy
Adult ; Aged ; Antineoplastic Agents/therapeutic use ; Brachytherapy/adverse effects ; Cisplatin/therapeutic use ; Cystitis/etiology ; Cystitis/pathology ; Disease-Free Survival ; Female ; Humans ; Hysterectomy ; Kaplan-Meier Estimate ; Magnetic Resonance Imaging/methods ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/mortality ; Neoplasm, Residual ; Positron-Emission Tomography/methods ; Proctitis/etiology ; Proctitis/pathology ; Prospective Studies ; Quality of Life ; Radiopharmaceuticals ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy, Image-Guided/adverse effects ; Tumor Burden ; Uterine Cervical Neoplasms/diagnostic imaging ; Uterine Cervical Neoplasms/mortality ; Uterine Cervical Neoplasms/therapy
Czasopismo naukowe
Tytuł :
Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT.
Autorzy :
Fuller D; Department of Radiation Oncology, Genesis Health Care Partners, Inc, San Diego, California. Electronic address: .
Wurzer J; Department of Radiation Oncology, Atlanticare, Egg Harbor, New Jersey.
Shirazi R; Department of Radiation Oncology, Genesis Health Care Partners, Inc, San Diego, California.
Bridge S; Department of Urology, Genesis Health Care Partners, Inc, San Diego, California.
Law J; Department of Radiation Oncology, Atlanticare, Egg Harbor, New Jersey.
Crabtree T; Advance Research Associates, Inc, Santa Clara, California.
Mardirossian G; Department of Radiation Oncology, Genesis Health Care Partners, Inc, San Diego, California.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Feb 01; Vol. 106 (2), pp. 291-299. Date of Electronic Publication: 2019 Oct 17.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Neoplasm Recurrence, Local/*radiotherapy
Prostatic Neoplasms/*radiotherapy
Radiosurgery/*methods
Re-Irradiation/*methods
Salvage Therapy/*methods
Aged ; Aged, 80 and over ; Androgen Antagonists/therapeutic use ; Biopsy ; Disease-Free Survival ; Dose Fractionation, Radiation ; Follow-Up Studies ; Humans ; Kallikreins/blood ; Male ; Middle Aged ; Neoplasm Grading ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Penile Erection/radiation effects ; Prostate ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/pathology ; Radiosurgery/adverse effects ; Re-Irradiation/adverse effects ; Salvage Therapy/adverse effects ; Time Factors
Czasopismo naukowe
Tytuł :
Estimating PTV Margins in Head and Neck Stereotactic Ablative Radiation Therapy (SABR) Through Target Site Analysis of Positioning and Intrafractional Accuracy.
Autorzy :
Mesko S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Wang H; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Tung S; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Wang C; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Pasalic D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Chapman BV; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Moreno AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Reddy JP; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Garden AS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Rosenthal DI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Gunn GB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Fuller CD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Morrison W; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Phan J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Jan 01; Vol. 106 (1), pp. 185-193. Date of Electronic Publication: 2019 Sep 30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Radiotherapy Setup Errors*
Head and Neck Neoplasms/*radiotherapy
Neoplasm Recurrence, Local/*radiotherapy
Radiosurgery/*methods
Aged ; Cone-Beam Computed Tomography/methods ; Dose Fractionation, Radiation ; Head and Neck Neoplasms/diagnostic imaging ; Head and Neck Neoplasms/pathology ; Humans ; Immobilization/methods ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Parotid Neoplasms/diagnostic imaging ; Parotid Neoplasms/radiotherapy ; Patient Positioning ; Prospective Studies ; Quality Improvement ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy, Image-Guided/methods ; Re-Irradiation/methods ; Skull Base Neoplasms/diagnostic imaging ; Skull Base Neoplasms/radiotherapy
Czasopismo naukowe
Tytuł :
Local Relapse After Breast-Conserving Therapy Versus Mastectomy for Extensive Pure Ductal Carcinoma In Situ ≥4 cm.
Autorzy :
Hamilton SN; Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Department of Radiation Oncology, British Cancer-Vancouver Centre, Vancouver, British Columbia, Canada. Electronic address: .
Nichol A; Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Department of Radiation Oncology, British Cancer-Vancouver Centre, Vancouver, British Columbia, Canada.
Wai E; Department of Radiation Oncology, British Columbia-Vancouver Island Centre, Victoria, British Columbia, Canada.
Gondara L; Department of Population Oncology, British Columbia Cancer-Vancouver Centre, Vancouver, British Columbia, Canada.
Velásquez García HA; Department of Population Oncology, British Columbia Cancer-Vancouver Centre, Vancouver, British Columbia, Canada; School of Population and Public Health, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Speers C; Breast Cancer Outcomes Unit, British Columbia Cancer-Vancouver Centre, Vancouver, British Columbia, Canada.
Diocee R; Breast Cancer Outcomes Unit, British Columbia Cancer-Vancouver Centre, Vancouver, British Columbia, Canada.
Truong P; Department of Radiation Oncology, British Columbia-Vancouver Island Centre, Victoria, British Columbia, Canada.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Feb 01; Vol. 103 (2), pp. 381-388. Date of Electronic Publication: 2018 Sep 22.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Breast Neoplasms/*surgery
Carcinoma in Situ/*surgery
Carcinoma, Ductal, Breast/*surgery
Mastectomy/*methods
Mastectomy, Segmental/*methods
Neoplasm Recurrence, Local/*diagnosis
Adult ; Aged ; Breast Neoplasms/radiotherapy ; Carcinoma in Situ/radiotherapy ; Carcinoma, Ductal, Breast/radiotherapy ; Female ; Follow-Up Studies ; Humans ; Incidence ; Middle Aged ; Proportional Hazards Models ; Radiotherapy/methods ; Radiotherapy Planning, Computer-Assisted ; Recurrence ; Risk
Czasopismo naukowe
Tytuł :
Stereotactic Body Radiation Therapy to the Prostate Bed: Results of a Phase 1 Dose-Escalation Trial.
Autorzy :
Sampath S; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California. Electronic address: .
Frankel P; Department of Computational and Quantitative Medicine, Division of Biostatistics, City of Hope National Medical Center, Duarte, California.
Vecchio BD; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California.
Ruel N; Department of Computational and Quantitative Medicine, Division of Biostatistics, City of Hope National Medical Center, Duarte, California.
Yuh B; Department of Urological Surgery, City of Hope National Medical Center, Duarte, California.
Liu A; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California.
Tsai T; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California.
Wong J; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Mar 01; Vol. 106 (3), pp. 537-545. Date of Electronic Publication: 2019 Nov 13.
Typ publikacji :
Clinical Trial, Phase I; Journal Article
MeSH Terms :
Neoplasm Recurrence, Local/*radiotherapy
Prostatic Neoplasms/*radiotherapy
Radiosurgery/*methods
Aged ; Aged, 80 and over ; Clinical Trials, Phase II as Topic ; Dose Fractionation, Radiation ; Follow-Up Studies ; Humans ; Kallikreins/blood ; Male ; Maximum Tolerated Dose ; Middle Aged ; Neoplasm Recurrence, Local/blood ; Postoperative Complications/blood ; Prostate-Specific Antigen/blood ; Prostatectomy ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/surgery ; Radiosurgery/adverse effects ; Time Factors
Czasopismo naukowe
Tytuł :
Post-Mastectomy Radiation Therapy in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Patients: Analysis of the HERA Trial.
Autorzy :
Abi Jaoude J; Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
de Azambuja E; Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), Brussels, Belgium.
Makki M; Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon.
Tamim H; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Tfayli A; Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon; Division of Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
Geara F; Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
Piccart M; Institut Jules Bordet and l'Université Libre de Bruxelles (U.L.B), Brussels, Belgium.
Poortmans P; Department of Radiation Oncology, Institut Curie & Paris Sciences & Lettres, PSL University, Paris, France.
Zeidan YH; Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Mar 01; Vol. 106 (3), pp. 503-510. Date of Electronic Publication: 2019 Oct 22.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
MeSH Terms :
Neoplasm Recurrence, Local*
Receptor, ErbB-2*
Breast Neoplasms/*chemistry
Breast Neoplasms/*radiotherapy
Adult ; Aged ; Analysis of Variance ; Antineoplastic Agents, Immunological/therapeutic use ; Breast Neoplasms/mortality ; Breast Neoplasms/therapy ; Chemotherapy, Adjuvant ; Female ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Postoperative Period ; Proportional Hazards Models ; Receptors, Estrogen ; Receptors, Progesterone ; Retrospective Studies ; Trastuzumab/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Initial Safety and Tumor Control Results From a "First-in-Human" Multicenter Prospective Trial Evaluating a Novel Alpha-Emitting Radionuclide for the Treatment of Locally Advanced Recurrent Squamous Cell Carcinomas of the Skin and Head and Neck.
Autorzy :
Popovtzer A; Rabin Medical Center Petah Tiqva, Petah Tiqva, Israel; Tel Aviv University, Tel Aviv, Israel. Electronic address: .
Rosenfeld E; Rabin Medical Center Petah Tiqva, Petah Tiqva, Israel.
Mizrachi A; Rabin Medical Center Petah Tiqva, Petah Tiqva, Israel; Tel Aviv University, Tel Aviv, Israel.
Bellia SR; Instituto Scientifico Romagnolo per Lo Studio e la Cura dei Tumori, (IRST)-IRCCS, Meldola, Italy.
Ben-Hur R; Rabin Medical Center Petah Tiqva, Petah Tiqva, Israel.
Feliciani G; Instituto Scientifico Romagnolo per Lo Studio e la Cura dei Tumori, (IRST)-IRCCS, Meldola, Italy.
Sarnelli A; Instituto Scientifico Romagnolo per Lo Studio e la Cura dei Tumori, (IRST)-IRCCS, Meldola, Italy.
Arazi L; Ben-Gurion University of the Negev, Beersheba, Israel.
Deutsch L; BioStats Statistical Consult, Merkez Renanim, Maccabim Israel.
Kelson I; Tel Aviv University, Tel Aviv, Israel.
Keisari Y; Tel Aviv University, Tel Aviv, Israel.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Mar 01; Vol. 106 (3), pp. 571-578. Date of Electronic Publication: 2019 Nov 20.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Brachytherapy/*methods
Carcinoma, Squamous Cell/*radiotherapy
Head and Neck Neoplasms/*radiotherapy
Neoplasm Recurrence, Local/*radiotherapy
Radium/*therapeutic use
Skin Neoplasms/*radiotherapy
Thorium/*therapeutic use
Aged ; Aged, 80 and over ; Alpha Particles/adverse effects ; Alpha Particles/therapeutic use ; Brachytherapy/adverse effects ; Brachytherapy/instrumentation ; Carcinoma, Squamous Cell/pathology ; Erythema/etiology ; Feasibility Studies ; Female ; Head and Neck Neoplasms/pathology ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Pain, Procedural/etiology ; Photography ; Pilot Projects ; Progression-Free Survival ; Prospective Studies ; Radium/adverse effects ; Safety ; Skin Neoplasms/pathology ; Skin Ulcer/etiology ; Thorium/adverse effects ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases.
Autorzy :
Redmond KJ; Department of Radiation Oncology and Molecular Radiation Sciences, The John Hopkins University, Baltimore, Maryland. Electronic address: .
Sciubba D; Neurological Surgery, The John Hopkins University, Baltimore, Maryland.
Khan M; Radiology, The John Hopkins University, Baltimore, Maryland.
Gui C; Department of Radiation Oncology and Molecular Radiation Sciences, The John Hopkins University, Baltimore, Maryland.
Lo SL; Neurological Surgery, The John Hopkins University, Baltimore, Maryland.
Gokaslan ZL; Department of Neurological Surgery, The Warren Alpert Medical School of Brown University, Providence, Rhode Island.
Leaf B; Department of Radiation Oncology and Molecular Radiation Sciences, The John Hopkins University, Baltimore, Maryland.
Kleinberg L; Department of Radiation Oncology and Molecular Radiation Sciences, The John Hopkins University, Baltimore, Maryland.
Grimm J; Department of Radiation Oncology and Molecular Radiation Sciences, The John Hopkins University, Baltimore, Maryland.
Ye X; Neurological Surgery, The John Hopkins University, Baltimore, Maryland.
Lim M; Neurological Surgery, The John Hopkins University, Baltimore, Maryland.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Feb 01; Vol. 106 (2), pp. 261-268. Date of Electronic Publication: 2019 Oct 16.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neoplasm Recurrence, Local*/diagnostic imaging
Radiosurgery/*methods
Spinal Neoplasms/*radiotherapy
Spinal Neoplasms/*secondary
Adult ; Aged ; Cancer Pain/diagnosis ; Disease Progression ; Dose Fractionation, Radiation ; Female ; Humans ; Karnofsky Performance Status ; Male ; Middle Aged ; Neurologic Examination/statistics & numerical data ; Pain Measurement/methods ; Postoperative Period ; Prospective Studies ; Radiation Tolerance ; Radiosurgery/adverse effects ; Spinal Neoplasms/diagnostic imaging ; Spinal Neoplasms/surgery ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Body Mass Index and Outcomes in Breast Cancer Treated With Breast Conservation.
Autorzy :
Patel V; Canterbury Regional Cancer and Blood Service, Christchurch Hospital, Christchurch, New Zealand, Radiation Oncology Department, Auckland City Hospital, Auckland, New Zealand. Electronic address: .
James M; Canterbury Regional Cancer and Blood Service, Christchurch Hospital, Christchurch, New Zealand, University of Otago Christchurch, Department of Medicine, Christchurch Hospital, Christchurch, New Zealand.
Frampton C; University of Otago Christchurch, Department of Medicine, Christchurch Hospital, Christchurch, New Zealand.
Robinson B; Canterbury Regional Cancer and Blood Service, Christchurch Hospital, Christchurch, New Zealand, University of Otago Christchurch, Department of Medicine, Christchurch Hospital, Christchurch, New Zealand.
Davey V; Christchurch Breast Cancer Patient Register, Department of General Surgery, Christchurch, New Zealand.
Timmings L; University of Otago Christchurch, Department of Medicine, Christchurch Hospital, Christchurch, New Zealand.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Feb 01; Vol. 106 (2), pp. 369-376. Date of Electronic Publication: 2019 Oct 31.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Body Mass Index*
Mastectomy, Segmental*
Neoplasm Recurrence, Local*/mortality
Breast Neoplasms/*surgery
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Breast Neoplasms/therapy ; Disease-Free Survival ; Female ; Humans ; Lymphatic Irradiation ; Lymphatic Metastasis ; Middle Aged ; Neoplasm Grading ; New Zealand/epidemiology ; Obesity/epidemiology ; Overweight/epidemiology ; Prospective Studies ; Treatment Outcome ; Tumor Burden ; Young Adult
Czasopismo naukowe
Tytuł :
The Risk Is Worth the Reward: Regional-Only Recurrence Is Curable with Nodal Dissection.
Autorzy :
Spiotto MT; Department of Radiation Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; Department of Radiation and Cellular Oncology, University of Chicago Medical Center, Chicago, Illinois.
Koshy M; Department of Radiation Oncology, University of Illinois Hospital and Health Sciences System, Chicago, Illinois; Department of Radiation and Cellular Oncology, University of Chicago Medical Center, Chicago, Illinois.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Feb 01; Vol. 106 (2), pp. 239-240.
Typ publikacji :
Letter; Comment
MeSH Terms :
Adenocarcinoma*
Neoplasm Recurrence, Local*
Humans ; Lymph Node Excision ; Male ; Prostate ; Reward
Opinia redakcyjna
Tytuł :
Patterns and Predictors of Relapse Following Radical Chemoradiation Therapy Delivered Using Intensity Modulated Radiation Therapy With a Simultaneous Integrated Boost in Anal Squamous Cell Carcinoma.
Autorzy :
Shakir R; Oxford Cancer and Haematology Centre, Oxford University Hospitals, Oxford, United Kingdom; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Adams R; Velindre Cancer Centre, Cardiff, United Kingdom.
Cooper R; Radiotherapy Research Group, Leeds Cancer Centre, St James's University Hospital, Leeds, United Kingdom.
Downing A; Leeds Institute for Medical Research at St James, University of Leeds, United Kingdom.
Geh I; Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
Gilbert D; Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, United Kingdom.
Jacobs C; Oxford Cancer and Haematology Centre, Oxford University Hospitals, Oxford, United Kingdom.
Jones C; Radiotherapy Research Group, Leeds Cancer Centre, St James's University Hospital, Leeds, United Kingdom; School of Molecular & Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.
Lorimer C; Sussex Cancer Centre, Royal Sussex County Hospital, Brighton, United Kingdom.
Namelo WC; Velindre Cancer Centre, Cardiff, United Kingdom.
Sebag-Montefiore D; Radiotherapy Research Group, Leeds Cancer Centre, St James's University Hospital, Leeds, United Kingdom; Leeds Clinical Trials Unit, Faculty of Medicine & Health, University of Leeds, United Kingdom.
Shaw P; Velindre Cancer Centre, Cardiff, United Kingdom; School of Biosciences, Cardiff University, United Kingdom.
Muirhead R; Oxford Cancer and Haematology Centre, Oxford University Hospitals, Oxford, United Kingdom. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Feb 01; Vol. 106 (2), pp. 329-339. Date of Electronic Publication: 2019 Oct 17.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Neoplasm Recurrence, Local*/mortality
Re-Irradiation*
Anus Neoplasms/*therapy
Carcinoma, Squamous Cell/*therapy
Chemoradiotherapy/*methods
Radiotherapy, Intensity-Modulated/*methods
Adult ; Aged ; Aged, 80 and over ; Anus Neoplasms/mortality ; Anus Neoplasms/radiotherapy ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/radiotherapy ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Practice Guidelines as Topic ; Retrospective Studies ; Risk Factors ; Salvage Therapy/statistics & numerical data ; Sex Factors ; Treatment Failure ; United Kingdom
Czasopismo naukowe
Tytuł :
Nodal Recurrence From Prostate Adenocarcinoma: Curable or Incurable?
Autorzy :
Rodríguez-López JL; Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA. Electronic address: .
Beriwal S; Department of Radiation Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Feb 01; Vol. 106 (2), pp. 236-237.
Typ publikacji :
Case Reports; Editorial
MeSH Terms :
Lymph Nodes*/diagnostic imaging
Adenocarcinoma/*therapy
Neoplasm Recurrence, Local/*therapy
Prostatic Neoplasms/*therapy
Adenocarcinoma/diagnostic imaging ; Adenocarcinoma/secondary ; Androstenes/therapeutic use ; Carboxylic Acids ; Combined Modality Therapy/methods ; Cyclobutanes ; Gonadotropin-Releasing Hormone/agonists ; Gonadotropin-Releasing Hormone/analogs & derivatives ; Humans ; Lymph Node Excision ; Lymphatic Irradiation ; Male ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Positron Emission Tomography Computed Tomography ; Prednisone/therapeutic use ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/pathology
Raport
Tytuł :
Selection of Head and Neck Cancer Patients for Intensive Therapy.
Autorzy :
Vitzthum LK; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.
Park H; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.
Zakeri K; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.
Bryant AK; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.
Feng C; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.
Shen H; Center for Precision Radiation Medicine, La Jolla, California.
Cohen EEW; Department of Medicine, Division of Hematology and Oncology, University of California San Diego, La Jolla, California.
Murphy JD; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; Center for Precision Radiation Medicine, La Jolla, California.
Mell LK; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California; Center for Precision Radiation Medicine, La Jolla, California. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Jan 01; Vol. 106 (1), pp. 157-166. Date of Electronic Publication: 2019 Sep 30.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neoplasm Recurrence, Local*
Nomograms*
Patient Selection*
Head and Neck Neoplasms/*radiotherapy
Squamous Cell Carcinoma of Head and Neck/*radiotherapy
Age Factors ; Aged ; Comorbidity ; Confidence Intervals ; Disease Progression ; Employment ; Female ; Head and Neck Neoplasms/classification ; Head and Neck Neoplasms/mortality ; Humans ; Male ; Middle Aged ; Proportional Hazards Models ; Radiotherapy, Intensity-Modulated ; Regression Analysis ; Risk Factors ; Smokers ; Squamous Cell Carcinoma of Head and Neck/classification ; Squamous Cell Carcinoma of Head and Neck/mortality ; Thinness/complications ; Veterans/statistics & numerical data
Czasopismo naukowe
Tytuł :
Outcome and Patterns of Relapse in Childhood Parameningeal Rhabdomyosarcoma Treated With Proton Beam Therapy.
Autorzy :
Doyen J; Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Germany; Department of Radiation Oncology, Centre Antoine-Lacassagne, University of Côte d'Azur, Fédération Claude Lalanne, Nice, France. Electronic address: .
Jazmati D; Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Germany.
Geismar D; Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Germany, German Cancer Consortium (DKTK).
Frisch S; Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Germany.
Schleithoff SS; Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Germany.
Vermeren X; West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), University Hospital Essen, Germany.
Scheer M; Pediatrics 5 (Oncology, Hematology, Immunology), Olgahospital, Klinikum Stuttgart, Stuttgart, Germany; Cooperative Weichteilsarkomstudiengruppe (CWS) Olgahospital, Pädiatrisches Zentrum der Landeshauptstadt, Klinikum Stuttgart, Germany; Department of Pediatric and Oncology, University Hospital of Stuttgart, Germany.
Blase C; Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Germany; AnästhesieNetz Rhein-Ruhr, Bochum, Germany.
Tippelt S; Department of Pediatric Oncology and Hematology, Pediatrics III, University Hospital Essen, Germany.
Timmermann B; Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), Germany, German Cancer Consortium (DKTK).
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Dec 01; Vol. 105 (5), pp. 1043-1054. Date of Electronic Publication: 2019 Aug 13.
Typ publikacji :
Evaluation Study; Journal Article; Review
MeSH Terms :
Neoplasm Recurrence, Local*/diagnostic imaging
Neoplasm Recurrence, Local*/mortality
Proton Therapy*/adverse effects
Meningeal Neoplasms/*radiotherapy
Rhabdomyosarcoma/*radiotherapy
Adolescent ; Analysis of Variance ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Child ; Child, Preschool ; Disease-Free Survival ; Feasibility Studies ; Female ; Follow-Up Studies ; Humans ; Infant ; Magnetic Resonance Imaging/methods ; Male ; Meningeal Neoplasms/diagnostic imaging ; Meningeal Neoplasms/mortality ; Meningeal Neoplasms/surgery ; Prognosis ; Radiation Injuries/pathology ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted ; Retrospective Studies ; Rhabdomyosarcoma/diagnostic imaging ; Rhabdomyosarcoma/mortality ; Rhabdomyosarcoma/surgery ; Rhabdomyosarcoma, Alveolar/diagnostic imaging ; Rhabdomyosarcoma, Alveolar/mortality ; Rhabdomyosarcoma, Alveolar/radiotherapy ; Rhabdomyosarcoma, Alveolar/surgery ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Stereotactic Ablative Radiation Therapy for Pulmonary Recurrence-Based Oligometastatic Non-Small Cell Lung Cancer: Survival and Prognostic Value of Regulatory T Cells.
Autorzy :
Liu C; Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China; Department of Radiation Oncology, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China.
Sun B; Department of Radiation Oncology, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China.
Hu X; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Zhang Y; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.
Wang Q; Department of Radiation Oncology, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, China.
Yue J; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. Electronic address: .
Yu J; Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, China; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Dec 01; Vol. 105 (5), pp. 1055-1064. Date of Electronic Publication: 2019 Aug 19.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
T-Lymphocytes, Regulatory*/cytology
Carcinoma, Non-Small-Cell Lung/*radiotherapy
Carcinoma, Non-Small-Cell Lung/*secondary
Neoplasm Recurrence, Local/*radiotherapy
Radiosurgery/*methods
Adrenal Gland Neoplasms/radiotherapy ; Adrenal Gland Neoplasms/secondary ; Adult ; Aged ; Aged, 80 and over ; Bone Neoplasms/radiotherapy ; Bone Neoplasms/secondary ; Brain Neoplasms/radiotherapy ; Brain Neoplasms/secondary ; Carcinoma, Non-Small-Cell Lung/immunology ; Carcinoma, Non-Small-Cell Lung/mortality ; Female ; Flow Cytometry ; Humans ; Immunity, Cellular ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Neoplasm Recurrence, Local/immunology ; Neoplasm Recurrence, Local/mortality ; Prognosis ; Progression-Free Survival ; Prospective Studies ; Regression Analysis
Czasopismo naukowe
Tytuł :
Carbon Ion Reirradiation for Recurrent Head and Neck Cancer: A Single-Institutional Experience.
Autorzy :
Held T; Heidelberg University Hospital, Department of Radiation Oncology, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Windisch P; Heidelberg University Hospital, Department of Radiation Oncology, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Akbaba S; Heidelberg University Hospital, Department of Radiation Oncology, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Lang K; Heidelberg University Hospital, Department of Radiation Oncology, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
El Shafie R; Heidelberg University Hospital, Department of Radiation Oncology, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Bernhardt D; Heidelberg University Hospital, Department of Radiation Oncology, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Plinkert P; Department of Otorhinolaryngology, University of Heidelberg, Heidelberg, Germany.
Kargus S; Department of Oral and Maxillofacial Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Rieken S; Heidelberg University Hospital, Department of Radiation Oncology, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany; German Cancer Consortium (DKTK), partner site Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Herfarth K; Heidelberg University Hospital, Department of Radiation Oncology, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany; German Cancer Consortium (DKTK), partner site Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Debus J; Heidelberg University Hospital, Department of Radiation Oncology, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany; German Cancer Consortium (DKTK), partner site Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Adeberg S; Heidelberg University Hospital, Department of Radiation Oncology, Heidelberg, Germany; Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany; National Center for Tumor Diseases (NCT), Heidelberg, Germany; Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany; German Cancer Consortium (DKTK), partner site Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Nov 15; Vol. 105 (4), pp. 803-811. Date of Electronic Publication: 2019 Jul 23.
Typ publikacji :
Journal Article
MeSH Terms :
Head and Neck Neoplasms/*radiotherapy
Heavy Ion Radiotherapy/*methods
Neoplasm Recurrence, Local/*radiotherapy
Re-Irradiation/*methods
Adenocarcinoma/mortality ; Adenocarcinoma/radiotherapy ; Aged ; Carcinoma, Adenoid Cystic/mortality ; Carcinoma, Adenoid Cystic/radiotherapy ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/radiotherapy ; Feasibility Studies ; Female ; Head and Neck Neoplasms/mortality ; Head and Neck Neoplasms/pathology ; Heavy Ion Radiotherapy/adverse effects ; Humans ; Male ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Progression-Free Survival ; Radiation Injuries/complications ; Radiation Injuries/pathology ; Radiotherapy Dosage ; Re-Irradiation/adverse effects ; Relative Biological Effectiveness ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Salvage Stereotactic Body Radiation Therapy for Local Prostate Cancer Recurrence After Radiation Therapy: A Retrospective Multicenter Study of the GETUG.
Autorzy :
Pasquier D; Academic Department of Radiation Oncology, Centre Oscar Lambret, Lille, France; CRIStAL UMR CNRS 9189, Lille University, Lille, France. Electronic address: .
Martinage G; Academic Department of Radiation Oncology, Centre Oscar Lambret, Lille, France.
Janoray G; Oncology-Radiotherapy Department, Henry-S.-Kaplan Cancer Center, CHRU de Tours, Tours, France; University François-Rabelais, Tours, France.
Rojas DP; Department of Radiotherapy, European Institute of Oncology and Department of Oncology and Hemato-oncology, University of Milan, Italy.
Zerini D; Department of Radiotherapy, European Institute of Oncology and Department of Oncology and Hemato-oncology, University of Milan, Italy.
Goupy F; Department of Radiotherapy, Centre Eugène Marquis, Rennes, France.
De Crevoisier R; Department of Radiotherapy, Centre Eugène Marquis, Rennes, France; INSERM 1099 Unit, Rennes, France; LTSI, Université de Rennes 1, Rennes, France.
Bogart E; Department of Biostatistics, Centre Oscar Lambret, Lille, France.
Calais G; Oncology-Radiotherapy Department, Henry-S.-Kaplan Cancer Center, CHRU de Tours, Tours, France; University François-Rabelais, Tours, France.
Toledano A; Department of Radiotherapy, Hartmann Radiotherapy Center, Levallois-Perret, France.
Chauveinc L; Department of Radiotherapy, Hartmann Radiotherapy Center, Levallois-Perret, France.
Scher N; Department of Radiotherapy, Hartmann Radiotherapy Center, Levallois-Perret, France.
Bondiau PY; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Cote d'Azur, Nice, France.
Hannoun-Levi JM; Department of Radiation Oncology, Antoine Lacassagne Cancer Center, University of Cote d'Azur, Nice, France.
Silva M; Department of Radiation Oncology, Centre François Baclesse, Caen, France.
Meyer E; Department of Radiation Oncology, Centre François Baclesse, Caen, France.
Nickers P; Academic Department of Radiation Oncology, Centre Oscar Lambret, Lille, France.
Lacornerie T; Department of Medical Physics, Centre Oscar Lambret, Lille, France.
Jereczek-Fossa BA; Department of Radiotherapy, European Institute of Oncology and Department of Oncology and Hemato-oncology, University of Milan, Italy.
Lartigau E; Academic Department of Radiation Oncology, Centre Oscar Lambret, Lille, France; CRIStAL UMR CNRS 9189, Lille University, Lille, France.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Nov 15; Vol. 105 (4), pp. 727-734. Date of Electronic Publication: 2019 Jul 22.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Radiosurgery*
Neoplasm Recurrence, Local/*radiotherapy
Prostatic Neoplasms/*radiotherapy
Salvage Therapy/*methods
Aged ; Aged, 80 and over ; Androgen Antagonists/therapeutic use ; Disease-Free Survival ; Gastrointestinal Diseases/etiology ; Humans ; Kallikreins/blood ; Kaplan-Meier Estimate ; Magnetic Resonance Imaging ; Male ; Male Urogenital Diseases/etiology ; Middle Aged ; Neoplasm Grading ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/pathology ; Positron-Emission Tomography ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/pathology ; Retrospective Studies ; Survival Rate ; Tumor Burden
Czasopismo naukowe
Tytuł :
Radiated, Reconstructed, Recurred.
Autorzy :
Bagley AF; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: .
Smith BD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Nov 01; Vol. 105 (3), pp. 471-472.
Typ publikacji :
Case Reports; Editorial
MeSH Terms :
Carcinoma, Intraductal, Noninfiltrating/*radiotherapy
Neoplasm Recurrence, Local/*radiotherapy
Neoplasms, Second Primary/*radiotherapy
Triple Negative Breast Neoplasms/*radiotherapy
Unilateral Breast Neoplasms/*radiotherapy
Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Breast Self-Examination ; Carcinoma, Intraductal, Noninfiltrating/diagnostic imaging ; Carcinoma, Intraductal, Noninfiltrating/drug therapy ; Carcinoma, Intraductal, Noninfiltrating/surgery ; Chemotherapy, Adjuvant ; Female ; Humans ; Lymphatic Irradiation ; Mammaplasty/methods ; Mastectomy/methods ; Middle Aged ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/surgery ; Neoplasms, Second Primary/diagnostic imaging ; Neoplasms, Second Primary/drug therapy ; Neoplasms, Second Primary/surgery ; Radiotherapy Dosage ; Radiotherapy, Adjuvant ; Re-Irradiation/methods ; Sentinel Lymph Node Biopsy ; Thoracic Wall/surgery ; Time Factors ; Triple Negative Breast Neoplasms/diagnostic imaging ; Triple Negative Breast Neoplasms/drug therapy ; Triple Negative Breast Neoplasms/surgery ; Unilateral Breast Neoplasms/surgery
Raport
Tytuł :
Distribution of Locoregional Breast Cancer Recurrence in Relation to Postoperative Radiation Fields and Biological Subtypes.
Autorzy :
Adra J; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahgrenska University Hospital, Gothenburg, Sweden.
Lundstedt D; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahgrenska University Hospital, Gothenburg, Sweden.
Killander F; Division of Oncology and Pathology, Institute of Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden.
Holmberg E; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahgrenska University Hospital, Gothenburg, Sweden.
Haghanegi M; Division of Oncology and Pathology, Institute of Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden.
Kjellén E; Division of Oncology and Pathology, Institute of Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden.
Karlsson P; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahgrenska University Hospital, Gothenburg, Sweden.
Alkner S; Division of Oncology and Pathology, Institute of Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden. Electronic address: .
Pokaż więcej
Źródło :
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2019 Oct 01; Vol. 105 (2), pp. 285-295. Date of Electronic Publication: 2019 Jun 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Breast Neoplasms/*epidemiology
Breast Neoplasms/*radiotherapy
Neoplasm Recurrence, Local/*epidemiology
Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/chemistry ; Breast Neoplasms/surgery ; Female ; Humans ; Incidence ; Mastectomy ; Middle Aged ; Neoplasm Recurrence, Local/chemistry ; Neoplasm Recurrence, Local/pathology ; Postoperative Care ; Practice Guidelines as Topic ; Receptor, ErbB-2 ; Receptors, Estrogen ; Receptors, Progesterone ; Retrospective Studies ; Sweden/epidemiology ; Time Factors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies